MRMarjan Razi-Khosroshahi

Marjan Razi-Khosroshahi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marjan Razi-Khosroshahi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Azadeh Shabani

    Preventive Gynecology Research Center (PGRC) Shahid Beheshti University of Medical Sciences Tehran Iran

    1 shared publication
  • Bahram Eshraghi

    Translational Ophthalmology Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran

    1 shared publication
  • David I Silbert

    Conestoga Eye, Lancaster, PA, USA

    1 shared publication
  • Hamide Rahmani Seraji

    Department of Hematology and Oncology, Taleghani Hospital Shahid Beheshti University of Medical Science Tehran Iran

    1 shared publication
  • Hamidreza Hasani

    Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Matin Hooshyar

    School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran

    1 shared publication

Latest Publications

  • Open Access

    Can COVID‐19 Lead to Refractory Thrombotic Thrombocytopenic Purpura (TTP) During Pregnancy and Postpartum? A Case Report and a Review of the Literature

    by Azadeh Shabani, Marjan Razi‐Khosroshahi, Hamide Rahmani Seraji, Nafiseh Faghih, Matin Hooshyar

    Thrombotic thrombocytopenic purpura (TTP) is a rare but fatal blood disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and multi‐organ dysfunction. This condition often worsens during pregnancy and the postpartum period due to physiological changes. The present study reports a case of refractory TTP in a pregnant woman with a history of positive COVID‐19 infection who required aggressive treatment throughout her pregnancy and postpartum recovery. A 41‐year‐old pregnant woman (G3P2L2; C/S × 2) presented at 6 weeks of gestation with sudden hematuria, fever, and a positive COVID‐19 PCR test. Laboratory findings revealed the presence of schistocytes on the blood smear and a platelet count of 10,000/μL, strongly suggestive of TTP. Following hematology and gastroenterology evaluations, treatment was initiated immediately with methylprednisolone (1 mg/kg) and plasma exchange (PLEX). At 11 weeks of gestation, the patient's platelet count decreased to 12,000/μL, with evidence of hemolysis. She underwent eight sessions of PLEX and continued oral prednisolone therapy (1 mg/kg). The patient was subsequently discharged with a platelet count of 300,000/μL. Weekly outpatient PLEX and oral prednisolone were maintained throughout the pregnancy. At 36 weeks of gestation, the patient presented with labor pain and headache, leading to an emergency cesarean section. Postoperatively, she underwent 10 additional PLEX sessions and continued oral prednisolone treatment. She was discharged after 2 weeks in stable condition, without further complications. In conclusion, post‐COVID‐19 TTP could affect women and poses substantial therapeutic challenges. This case study highlights the complexities involved in managing refractory TTP during pregnancy and the postpartum period.

  • Pediatric posttraumatic orbital subperiosteal hematoma

    by Bahram Eshraghi, Marjan Razi-Khosroshahi, Hamidreza Hasani, David I Silbert

    Aim: To report five children with posttraumatic orbital subperiosteal hematoma. Methods: In this study, five cases with posttraumatic orbital subperiosteal hematoma were studied and reviewed along with similar cases in a systematic literature review. Results: The mean age of our patients was 9.40 ± 3.51 years, ranging from 4 to 13 years, and all were male. Mechanisms of injuries were blunt trauma, falling from a building, car accident, and falling from a bicycle. All patients had unilateral involvement. Treatment options included needle aspiration, surgical drainage, and observation for spontaneous resolution. Except for one patient, positive outcomes were achieved. Conclusion: The most common location for posttraumatic orbital subperiosteal hematoma is the superior orbital wall. Traumatic optic neuropathy and permanent visual loss are uncommon. Observation, surgical drainage, and aspiration are common treatment options.